Table 1.
Category | Total HIV Subjects | IC1 | IC2 | IC3 | Control | |
---|---|---|---|---|---|---|
N a | 62 | 20 | 33 (4) b | 9 (5) b | 20 | |
Age c | 7 (0.9 – 13) | 7(0.9 – 13) | 6(1.5 – 12) | 6 (3 – 13) | 7 (1 – 12) | |
VL (Log 10)c copies / ml | 4.96 (3.65 – 5.87) | 4.7 (3.65 – 5.88) | 4.97 (3.75 – 5.88) | 5.32 (4.73 – 5.69) | -- | |
Hemoglobin (gm/dl) d | 10.96 ± 1.4 | 10.73 ± 1.45 | 10.96 ± 1.51 | 11.19 ± 1.23 | 10.51 ± 1.30 | |
CD3 d | % | 79 ± 10 | 79 ± 8 | 78 ± 7 | 81 ± 14 | 66 ± 10 |
Cells/mm3 | 2878 ± 1439 | 2954 ± 1079 | 2899 ± 1374 | 2780 ± 1864 | 4131 ± 2791 | |
CD4 d | % | 21 ± 4 | 32 ± 5 | 21 ± 3 | 9 ± 3 | 33 ± 8 |
Cells/mm3 | 766 ± 374 | 1213 ± 530 | 809 ± 459 | 275 ± 132 | 2147 ± 1452 | |
CD8 d | % | 53 ± 10 | 42 ± 8 | 51 ± 8 | 66 ± 14 | 29 ± 10 |
Cells/mm3 | 1909 ± 1041 | 1557 ± 578 | 1885 ± 883 | 2286 ± 1661 | 1764 ±1 446 | |
CD19 d | % | 10 ± 6 | 12 ± 7 | 11 ± 5 | 8 ± 5 | 23 ± 8 |
Cells/mm3 | 388 ± 335 | 459 ± 375 | 465 ± 450 | 240 ± 179 | 1338 ± 939 | |
CD16+56 d | % | 17 ± 4 | 5 ± 3 | 7 ± 6 | 5 ± 4 | 9 ± 5 |
Cells/mm3 | 220 ± 197 | 193 ± 130 | 306 ± 313 | 161 ± 149 | 485 ± 389 | |
DC d | % | 0.36 ± 0.03 | 0.31 ± 0.13 | 0.38 ± 0.28 | 0.40 ± 0.14 | 0.67 ± 0.32 |
Cells/mm3 | 31 ± 2 | 27 ± 14 | 31 ± 17 | 33 ± 18 | 86 ± 66 | |
mDC d | % | 0.26 ± 0.02 | 0.24 ± 0.09 | 0.26 ± 0.20 | 0.28 ± 0.09 | 0.44 ± 0.20 |
Cells/mm3 | 22 ± 2 | 21 ± 11 | 22 ± 13 | 23 ± 12 | 57 ± 43 | |
pDC d | % | 0.1 ± 0.01 | 0.07 ± 0.05 | 0.12 ± 0.10 | 0.12 ± 0.07 | 0.23 ± 0.14 |
Cells/mm3 | 9 ± 1 | 6 ± 4 | 10 ± 6 | 10 ± 7 | 29 ± 24 |
N - Number of samples
Values in the brackets – Number of children initiated HAART
Data are median (range)
Data are mean ± SD